ArticleOncoTargets and therapy2021

AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest.

Wei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.